Allergic rhinitis: indicators of quality of life.

The objective of this review was to present evidence of the relationship between allergic rhinitis and impairment of quality of life. The data sources were original articles, reviews and consensus statements entered into the Medline and LILACS databases between 1997 and 2008. The following search terms were used: 'allergic rhinitis'; 'quality of life'; and 'sleep disorders'. Quality of life is often impaired in patients with allergic rhinitis, due to the classic symptoms of the disease (sneezing, pruritus, rhinorrhea and nasal obstruction). In addition, the pathophysiology of allergic rhinitis often disrupts sleep, leading to fatigue, irritability, memory deficits, daytime sleepiness and depression. The total burden of this disease goes beyond impairment of physical and social functioning. It has also a financial impact, which becomes greater when we consider the evidence that allergic rhinitis is a possible causal factor of comorbidities, such as asthma and sinusitis. Nasal obstruction, the most prominent symptom, is associated with sleep disorders, which can have a profound effect on mental health, learning, behavior and attention. Finally, allergic rhinitis-a chronic condition that affects adults, adolescents and children-is often underdiagnosed or inadequately treated. The deleterious impact that allergic rhinitis-related sleep disorders have on patient capacity to perform activities of daily living is an important component of the morbidity of the disease. With an accurate diagnosis, there are various available treatments that can reduce the burden of allergic rhinitis.

[1]  M. Rottem.  [Allergic rhinitis and its impact on asthma]. , 2010, Harefuah.

[2]  L. Bielory,et al.  Intranasal corticosteroids and allergic rhinoconjunctivitis , 2008, Current opinion in allergy and clinical immunology.

[3]  P. Camargos,et al.  Allergic rhinitis: epidemiological aspects, diagnosis and treatment. , 2008, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[4]  E. Valovirta,et al.  The voice of the patients: allergic rhinitis is not a trivial disease , 2008, Current opinion in allergy and clinical immunology.

[5]  W. Fokkens,et al.  Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen , 2007, Allergy.

[6]  I. Camelo-Nunes.  New antihistamines: a critical view. , 2006, Jornal de pediatria.

[7]  Benjamin Eng,et al.  Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective , 2006, Current medical research and opinion.

[8]  T. Craig,et al.  How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? , 2005, The Journal of allergy and clinical immunology.

[9]  T. Craig,et al.  The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. , 2005, Allergy and asthma proceedings.

[10]  C. Naspitz,et al.  Is rhinitis alone or associated with atopic eczema a risk factor for severe asthma in children? , 2005, Pediatric Allergy and Immunology.

[11]  M. Blaiss,et al.  A study to determine the impact of rhinitis on sufferers' sleep and daily routine , 2005 .

[12]  D. Cherry,et al.  National Ambulatory Medical Care Survey: 2002 summary. , 2004, Advance data.

[13]  C. Pashos,et al.  Economic impact and quality-of-life burden of allergic rhinitis , 2004, Current medical research and opinion.

[14]  T. Casale,et al.  Clinical Implications of the Allergic Rhinitis‐Asthma Link , 2004, The American journal of the medical sciences.

[15]  L. Dupclay,et al.  Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  L. Mansfield,et al.  Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  S. Spector,et al.  Symptom severity assessment of allergic rhinitis: part 1. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  M. Blaiss.  Important aspects in management of allergic rhinitis: compliance, cost, and quality of life. , 2003, Allergy and asthma proceedings.

[19]  W. Berger.  Overview of allergic rhinitis. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  E. Lehman,et al.  Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis , 2003, Allergy.

[21]  E. Juniper,et al.  A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. , 2003, The Journal of allergy and clinical immunology.

[22]  J. Murray,et al.  Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. , 2002, Allergy and asthma proceedings.

[23]  H. Krouse,et al.  Immune Mediators in Allergic Rhinitis and Sleep , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[24]  E. Schenkel,et al.  Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis , 2001, Allergy.

[25]  G. Lack.  Pediatric allergic rhinitis and comorbid disorders. , 2001, The Journal of allergy and clinical immunology.

[26]  E. Meltzer,et al.  Quality of life in adults and children with allergic rhinitis. , 2001, The Journal of allergy and clinical immunology.

[27]  J Bousquet,et al.  Quality of life in allergic rhinitis and asthma. A population-based study of young adults. , 2000, American journal of respiratory and critical care medicine.

[28]  G. Scadding,et al.  Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis. , 2000, Clinical otolaryngology and allied sciences.

[29]  G. Kay,et al.  The effects of antihistamines on cognition and performance. , 2000, The Journal of allergy and clinical immunology.

[30]  D. Gustafsson,et al.  Development of allergies and asthma in infants and young children with atopic dermatitis – a prospective follow‐up to 7 years of age , 2000, Allergy.

[31]  S. Sullivan,et al.  The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. , 1999, The Journal of allergy and clinical immunology.

[32]  T. Casale,et al.  Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[33]  E. Juniper,et al.  Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. , 1999, The Journal of allergy and clinical immunology.

[34]  E. Meltzer,et al.  Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  J. Bousquet,et al.  Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. , 1999, The Journal of allergy and clinical immunology.

[36]  E. Meltzer,et al.  Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis , 1999 .

[37]  L. Bruschini,et al.  Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors , 1999, Allergy.

[38]  S. Spector,et al.  Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[39]  J. Owens,et al.  Sleep and Daytime Behavior in Children With Obstructive Sleep Apnea and Behavioral Sleep Disorders , 1998, Pediatrics.

[40]  D. Gozal.  Sleep-disordered breathing and school performance in children. , 1998, Pediatrics.

[41]  B. Lundbäck,et al.  Epidemiology of rhinitis and asthma. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  D. Ford,et al.  Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. , 1997, American journal of epidemiology.

[43]  E. Meltzer.  The prevalence and medical and economic impact of allergic rhinitis in the United States. , 1997, The Journal of allergy and clinical immunology.

[44]  P. Fireman.  Treatment of allergic rhinitis: effect on occupation productivity and work force costs. , 1997, Allergy and asthma proceedings.

[45]  S. Spector.  Overview of comorbid associations of allergic rhinitis. , 1997, The Journal of allergy and clinical immunology.

[46]  W. Flemons,et al.  Quality of life consequences of sleep-disordered breathing. , 1997, The Journal of allergy and clinical immunology.

[47]  T. Young,et al.  Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. , 1997, The Journal of allergy and clinical immunology.

[48]  T. Casale,et al.  Managing impairment in patients with allergic rhinitis. , 2006, Allergy and asthma proceedings.

[49]  Bashar Allaf,et al.  Severity and impairment of allergic rhinitis in patients consulting in primary care. , 2006, The Journal of allergy and clinical immunology.

[50]  R. Green,et al.  THE BURDEN OF ALLERGIC RHINITIS , 2005 .

[51]  V. Chinchilli,et al.  The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. , 2003, Allergy and asthma proceedings.

[52]  W. Crown,et al.  Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. , 2002, The Journal of allergy and clinical immunology.

[53]  Jan Born,et al.  Brain-immune interactions in sleep. , 2002, International review of neurobiology.

[54]  C E Reed,et al.  Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. , 1999, The Journal of allergy and clinical immunology.